Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE Group — Investor Presentation (March 2021)
20 slides from Scienture's investor presentation, Mar 1, 2021
Slide 1: Digitalizing the Retail Pharmacy Experience – Investor Presentation
IRE" gitalizing the Retail Pharthacd Experience | Investor Presentation . February 2021 NASDAQ: MEDS
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts, including, but not limited to, statements regarding future operations, financial results, cash flows
Slide 3: About TRxADE Group, Inc.
About TRxADE Group, Inc. TRXADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. * Market Leader: Operates the largest technology platform servin
Slide 4: Divisions of TRxADE Group
Divisions of TRxADE Group Platform Company with Various B2B + B2C Subsidiaries* 2<) TRADE \ MEDCHEKS (Health Passport) a) BONUM N HEALTH (TeleHealth) COMMUNITY SPECIALTY PHARMACY PHARMA SOLUTIONS. (Rx Distributor) (Pharmacy) “Innovation Lab” (Technology Bridge) 1) Pie slices not representative of re
Slide 5: TRxADE Marketplace
TRxADE Marketplace Independent Pharmacy Our B2B Pharmaceutical Supply Chain Platform Nationwide Footprint U.S. Pharmaceutical Industry! Growth TRxADE * Projected $685B per year industry size by 2023 and growing; Over 65,000 Opportunity Registered pharmacy facilities Users * Approximately 9 out of 10
Slide 6: TRxADE Marketplace
TRxADE Marketplace = Our B2B Pharmaceutical Supply Chain Platform Our Marketplace Solution *TRxADE’s exchange platform offers a clear and concise interface that allows registered independent pharmacies to analyze “up-to-the-minute” supply & pricing from multiple pharma suppliers «Economies of scale
Slide 7: Bonum Health
HEALTH Bonum Health row Patient Centric Telehealth Services Access to Board-Certified Providers & Health Assessment Tools from Anywhere Individually or through an employer sponsored program, patients can access board-certified medical providers nationwide using the Bonum Health mobile app, website o
Slide 8: Healthcare Infrastructure
Healthcare Infrastructure Pharmacy & Wholesale Divisions Broaden Capabilities INTEGRA PHARMA SOLUTIONS Integra Pharma Solutions Integra Pharma Solutions is the pharmaceutical supplier of choice for healthcare organizations of all sizes. The Company’s expertise in the distribution of products extends
Slide 9: MedCheks Digital Health Passport
MedCheks Digital Health Passport Secure Display of Vaccination & COVID-19 Test Result Status The MedCheks Health Passport, currently in development, will store an individual’s health records safely in one place leveraging state-of-the- art encryption & blockchain technology, allowing the holder to s
Slide 10: Tomorrow’s Digital Health Services Opportunity
Tomorrow’s Digital Health Services Opportunity Current Pharmacy Services Landscape Retail Pharmacy Shortcomings Non-Insurance based technology providers *Lack of a comprehensive model to optimize Prime * GoodRx © RO Vendor contracts and alternate source vendors to + Hims + Phil lower drug cost effec
Slide 11: TRxADE’s Opportunity
TRxADE’s Opportunity The Opportunity Digitally unify brick and mortar retail pharmacies to deliver exceptional patient-centric health services We believe the industry needs: A true partner with experience and resources to create complex bridges between fragmented healthcare services to drive coordin
Slide 12: TRxADE’s Future Vision: A Digital Health Services Ecosystem
TRXADE’s Future Vision: A Digital Health Services Ecosystem* Goal to Create a Trusted Technology Platform Delivering Exceptional Patient Health Outcomes Telemedicine Telepharmacy Digital Health Passport Access to a licensed physician Access to a licensed network pharmacist | Comprehensive digital va
Slide 13: TRxADE Industry Comparable Companies
TRxADE Industry Comparable Companies? Valuation? Category: Prescription TRxADE $60M Secondary Marketplace Distribution (B2B) henry Gana Amerisource (Good Neighbor Pharmacy) $21B Primary Supplier Retail Distribution McKesson (Healthmart) $288 Primary Supplier Cardinal (Leader) $15B Primary Supplier C
Slide 14: Selected Financials
Selected Financials * Rapid Growth: 94% YoY growth in FY2019 with strong sequential growth, recent revenue growth bolstered by wholesale transactions * High Margin: Revenue from transaction fees on marketplace platform (Credit Card/PayPal model) does not include the drugs value (over $100M annually)
Slide 15: Management
Management Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of TRxADE Group, Inc., a Nevada corporation (“TRxADE Nevada”) (our predecessor company) on January 8, 2014, and a
Slide 16: Key Takeaways
Key Takeaways NASDAQ:MEDS TRXADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. A Tech Focused Healthcare Services Company Market Leader: Opera
Slide 17: Investor Relations Contact
Investor Relations Contact Lucas A. Zimmerman Senior Vice President MZ North America Main: 949-259-4987 MEDS@mzgroup.us Wwww.mzgroup.us Contact Us TRXADE Group, Inc. 3840 Land O' Lakes Boulevard Land O'Lakes, FL 34639 (800) 261-0281 www.trxadegroup.com @TRADE www.trxade.com www.rxintegra.com www.bon
Slide 18: Appendix: Consolidated Balance Sheet
Appendix: Consolidated Balance Sheet Assets Accounts Receivable, net Inventory Prepaid Assets Deposits for Inventory purchases Total Current Assets Property Plant and Equipment, Net Other Assets Deposits Deferred Offering Costs Right-of-use leased assets Goodwill Total Assets Liabilities and Shareho
Slide 19: Appendix: Consolidated Statements of Operations
Appendix: Consolidated Statements of Operations Trxade Group, Inc. Consolidated Statements of Operations For the Three and Nine Months Ended September 30, 2020 and 2019 (unaudited) Three months ended Nine months ended 2020 2019 2020 2019 Revenues $ 6,332,269 $ 2,311,426 $ 15,128,226 $ 5,740,361 Cost
Slide 20: Appendix: Reconciliation of Net Income to Adj. EBITDA
Appendix: Reconciliation of Net Income to Adj. EBITDA? For the three months ended For the nine months ended September 30, September 30, 2020 2019 2020 2019 Net Income (loss) attributable to Trxade Group, Inc. $ 138,391 $ 27,565 $ (223,893) $ 210,775 Add (deduct): Interest, net 7,430 13,385 22,664 46